Mylan to Buy Strides Injectables Division for $1.6 Billion

Jason Cohn/Bloomberg

The Mylan Inc. headquarters is pictured in Canonsburg, Pennsylvania. The agreement with India’s Strides Arcolab Ltd. will broaden Mylan’s portfolio of off-patent injectable medicines that are in high demand because of shortages in the U.S.